GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Zhenyuan Share Co Ltd (SZSE:000705) » Definitions » Capex-to-Revenue

Zhejiang Zhenyuan Share Co (SZSE:000705) Capex-to-Revenue : 0.08 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Zhejiang Zhenyuan Share Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Zhejiang Zhenyuan Share Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-81.25 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥1,044.65 Mil.

Hence, Zhejiang Zhenyuan Share Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.08.


Zhejiang Zhenyuan Share Co Capex-to-Revenue Historical Data

The historical data trend for Zhejiang Zhenyuan Share Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Zhenyuan Share Co Capex-to-Revenue Chart

Zhejiang Zhenyuan Share Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.01 0.02 0.03 0.05

Zhejiang Zhenyuan Share Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.06 0.05 0.07 0.08

Competitive Comparison of Zhejiang Zhenyuan Share Co's Capex-to-Revenue

For the Drug Manufacturers - General subindustry, Zhejiang Zhenyuan Share Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Zhenyuan Share Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Zhenyuan Share Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Zhenyuan Share Co's Capex-to-Revenue falls into.



Zhejiang Zhenyuan Share Co Capex-to-Revenue Calculation

Zhejiang Zhenyuan Share Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-194.056) / 4106.372
=0.05

Zhejiang Zhenyuan Share Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-81.254) / 1044.651
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Zhenyuan Share Co  (SZSE:000705) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Zhejiang Zhenyuan Share Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Zhenyuan Share Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Zhenyuan Share Co (SZSE:000705) Business Description

Traded in Other Exchanges
N/A
Address
No. 289 Jiefang North Road, Zhejiang Province, Shaoxing, CHN, 312000
Zhejiang Zhenyuan Share Co Ltd is a China based pharmaceutical company. It is engaged in the engaged in the production and operation of proprietary Chinese medicines, Chinese herbal medicines, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, narcotic drugs, psychotropic drugs, medical devices, chemical reagent and others. Further, the firm's business scope covers the pharmaceutical industry, pharmaceutical business, pharmaceutical logistics and health service industry. It holds presence in both Chinese and international market.
Executives
Zhang Yan Na Supervisors
Wu Hai Ming Director
Chen Fu Gen Directors, executives
Wei Min Executives
He Yi Qiang Directors, executives
Dong Jin Biao Supervisors
Xuan Le Xin Supervisors
Jiang Guan Gen Supervisors
Song Yi Ting Directors, executives
Li Cheng Hua Executives
He Yu Long Directors, executives
Li Yang Executives
Ruan Jian Chang Director
Jin Ming Hua Executives
Zhou Qian Li Secretary Dong

Zhejiang Zhenyuan Share Co (SZSE:000705) Headlines

No Headlines